Sherman Jeffrey W's Form 4 filing
Horizon Therapeutics Public Ltd Co (HZNP) · filed Dec 13, 2022
- Accession no.
- 0001209191-22-060901
- Filed
- Dec 13, 2022
- Trade date
- May 27-Dec 12, 2022
- Filing delay
- 200 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.16M. It was filed 200 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sherman Jeffrey WCIK 0001230482 | Officer (EVP and Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 27, 2022 | Ordinary Shares | GGiftDisposed | −8,531 | $0.00 | $0 | 2,375 | Direct | |
| May 27, 2022 | Ordinary Shares | GGiftAcquired | +8,531 | $0.00 | $0 | 61,475 | Indirect | |
| Dec 12, 2022 | Ordinary Shares | SSaleDisposed | −6,974 | $111.44 | −$777,182.56 | 54,501 | Indirect | |
| Dec 12, 2022 | Ordinary Shares | SSaleDisposed | −21,378 | $111.45 | −$2,382,578.1 | 84,430 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.